Significance of persistent left ventricular dysfunction during recovery after dobutamine stress echocardiography
A Tsoukas,
I Ikonomidis,
P Cokkinos,
and
P Nihoyannopoulos
Department of Medicine, Hammersmith Hospital, Royal Postgraduate Medical School, London, England, United Kingdom.
OBJECTIVES: This study sought to determine the duration of new or worsening left ventricular regional wall motion abnormalities (RWMAs) after dobutamine stress echocardiography (DSE) and their relation to the extent of coronary artery disease (CAD). BACKGROUND: Despite extensive reports on DSE, little is known about the duration of new or worsening RWMAs during recovery. We hypothesized that the persistence of RWMAs during recovery may be associated with the extent of CAD and therefore ischemia. METHODS: Sixty-five consecutive patients with positive results on DSE and angiographically documented CAD were studied. Each patient underwent 12-lead electrocardiography and two-dimensional echocardiography at rest, during dobutamine infusion and continuously during recovery to assess the recovery time of ischemic myocardial regions. RESULTS: All patients had at least one ischemic region during DSE. Complete resolution of RWMAs occurred within 25 min in patients with multivessel CAD, within 20 min in those with two-vessel disease and within 15 min in those with single-vessel disease (p < 0.001). The greater the wall motion score index at peak stress, the longer the duration of RWMAs into the recovery phase (p < 0.01). RWMAs persisted long after normalization of each patient's symptoms, electrocardiographic (ECG) changes, heart rate and rate-pressure product during recovery. CONCLUSIONS: We demonstrated that normalization of left ventricular RWMAs occurs after resolution of symptoms and ECG changes during recovery. The time to recovery is related to the extent of CAD and myocardial ischemia as well as to the presence or absence of collateral circulation. These findings may represent stunned myocardium after brief period of ischemia.
This article has been cited by other articles:

|
 |

|
 |
 
P. Nihoyannopoulos and J. L. Vanoverschelde
Myocardial ischaemia and viability: the pivotal role of echocardiography
Eur. Heart J.,
April 1, 2011;
32(7):
810 - 819.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Sicari, P. Nihoyannopoulos, A. Evangelista, J. Kasprzak, P. Lancellotti, D. Poldermans, J.-U. Voigt, J. L. Zamorano, and on behalf of the European Association of Echocardi
Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC)
Eur Heart J Cardiovasc Imaging,
July 1, 2008;
9(4):
415 - 437.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Karagiannis, H. H.H. Feringa, J. J. Bax, A. Elhendy, M. Dunkelgrun, R. Vidakovic, S.E. Hoeks, R. van Domburg, R. Valhema, D. V. Cokkinos, et al.
Myocardial viability estimation during the recovery phase of stress echocardiography after acute beta-blocker administration
Eur J Heart Fail,
April 1, 2007;
9(4):
403 - 408.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Ikonomidis, G. Athanassopoulos, J. Lekakis, K. Venetsanou, M. Marinou, K. Stamatelopoulos, D. V. Cokkinos, and P. Nihoyannopoulos
Myocardial Ischemia Induces Interleukin-6 and Tissue Factor Production in Patients With Coronary Artery Disease: A Dobutamine Stress Echocardiography Study
Circulation,
November 22, 2005;
112(21):
3272 - 3279.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R Senior, M Monaghan, H Becher, J Mayet, and P Nihoyannopoulos
Stress echocardiography for the diagnosis and risk stratification of patients with suspected or known coronary artery disease: a critical appraisal. Supported by the British Society of Echocardiography
Heart,
April 1, 2005;
91(4):
427 - 436.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. o. Cosar and C. J. O'Connor
Hibernation, Stunning, and Preconditioning: Historical Perspective, Current Concepts, Clinical Applications, and Future Implications
Seminars in Cardiothoracic and Vascular Anesthesia,
June 1, 2003;
7(2):
115 - 140.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Mathias Jr, J. M. Tsutsui, J. L. Andrade, I. Kowatsch, P. A. Lemos, S. M. B. Leal, B. K. Khandheria, and J. F. Ramires
Value of rapid beta-blocker injectionat peak dobutamine-atropine stressechocardiography for detection of coronary artery disease
J. Am. Coll. Cardiol.,
May 7, 2003;
41(9):
1583 - 1589.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Kloner and R. B. Jennings
Consequences of Brief Ischemia: Stunning, Preconditioning, and Their Clinical Implications: Part 1
Circulation,
December 11, 2001;
104(24):
2981 - 2989.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E Barnes, C S R Baker, D P Dutka, O Rimoldi, C A Rinaldi, P Nihoyannopoulos, P G Camici, and R J C Hall
Prolonged left ventricular dysfunction occurs in patients with coronary artery disease after both dobutamine and exercise induced myocardial ischaemia
Heart,
March 1, 2000;
83(3):
283 - 289.
[Abstract]
[Full Text]
|
 |
|
|